SELLAS Life Sciences (SLS) EBT Margin (2012 - 2022)

SELLAS Life Sciences (SLS) reported EBT Margin of 1673.5% for Q1 2022, down 163411.0% year-over-year from N/an in Q1 2021, and down 614.05% quarter-over-quarter from 234.37% in Q2 2021.

SELLAS Life Sciences (SLS) EBT Margin (2012 - 2022) Analysis & Trends

SELLAS Life Sciences (SLS) has 7 years of EBT Margin data on file, last reported at 1673.5% in Q1 2022.

  • EBT Margin for Q1 2022 came in at 1673.5%, down 163411.0% year-over-year; the trailing twelve-month figure through Dec 2022 was 4195.0% (down 386218.0% YoY), and the FY2022 annual result was 4130.1%, down 385463.0% from the prior year.
  • EBT Margin slipped to 1673.5% in Q1 2022 per SLS's latest filing, from 234.37% in the prior quarter.
  • Over five years, EBT Margin peaked at 39.39% in Q1 2021 and troughed at 1673.5% in Q1 2022.
  • A 3-year average of 541.54% and a median of 226.63% in 2021 frame the typical range for EBT Margin.
  • On a YoY basis, EBT Margin climbed as much as 163411 bps in 2022 and fell as far as 163411 bps in 2022.
  • A 3-year view of EBT Margin shows it stood at 218.89% in 2020, then retreated by 7 bps to 234.37% in 2021, then slumped by 614 bps to 1673.5% in 2022.
  • Business Quant data shows SLS's EBT Margin at 1673.5% in Q1 2022, 234.37% in Q2 2021, and 39.39% in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 -1,673.50%
Jun 30, 2021 -234.37%
Mar 31, 2021 -39.39%
Dec 31, 2020 -218.89%
Jun 30, 2015 -268.57%
Mar 31, 2015 -324.07%
Dec 31, 2014 -303.38%
Sep 30, 2014 -652.28%
Jun 30, 2014 -698.16%
Mar 31, 2014 -545.28%
Dec 31, 2013 -1,315.68%
Sep 30, 2013 -501.73%
Jun 30, 2013 -345.60%
Mar 31, 2013 -554.76%
Dec 31, 2012 410.51%
Sep 30, 2012 -535.13%